Veracyte to Present at the Piper Jaffray 29th Annual Healthcare Conference
November 15 2017 - 10:00AM
Business Wire
Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H.
Anderson, chairman and chief executive officer, will present at the
Piper Jaffray 29th Annual Healthcare Conference on Tuesday,
November 28, 2017 at 9:30 a.m. Eastern Time in New York, NY.
The live webcast from the Piper Jaffray presentation and
subsequent replay may be accessed by visiting Veracyte's website at
http://investor.veracyte.com. The replay of the webcast will be
available shortly after the conclusion of the presentation and
archived on the company's website for 90 days following the
presentation.
About Veracyte
Veracyte (NASDAQ: VCYT) is a leading genomic diagnostics company
that is fundamentally improving patient care by resolving
diagnostic uncertainty with evidence that is trustworthy and
actionable. The company’s products uniquely combine genomic
technology, clinical science and machine learning to provide
answers that give physicians and patients a clear path forward
without risky, costly surgery that is often unnecessary. Since its
founding in 2008, Veracyte has commercialized three genomic tests,
which are transforming the diagnosis of thyroid cancer, lung cancer
and idiopathic pulmonary fibrosis and collectively target a $2
billion market opportunity. Veracyte is based in South San
Francisco, California. For more information, please visit
www.veracyte.com and follow the company on Twitter (@veracyte).
Veracyte and the Veracyte logo are trademarks of Veracyte,
Inc.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171115005548/en/
Veracyte, Inc.Media:Tracy Morris,
650-380-4413tracy.morris@veracyte.comorInvestors:Jackie
Cossmon, 650-243-6371jackie@veracyte.com
Veracyte (NASDAQ:VCYT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Veracyte (NASDAQ:VCYT)
Historical Stock Chart
From Mar 2023 to Mar 2024